November 08, 2021
A whistleblower has voluntarily dropped his 19-year-old False Claims Act lawsuit alleging the drugmaker Sanofi U.S. Services Inc. misleadingly promoted off-label uses for its cancer therapy drug, after the parties reached a confidential settlement less than three months before the case was set for trial.
November 12, 2020
A Pennsylvania federal judge on Thursday handed drugmaker Sanofi U.S. Services Inc. a win on some allegations in a whistleblower's 18-year-old False Claims Act lawsuit, but allowed other claims that the drugmaker misleadingly promoted off-label uses for its cancer therapy drug to head to trial.
April 17, 2020
A Pennsylvania federal judge tore into drugmaker Aventis for a last-minute motion to compel discovery in an 18-year-old false claims case, explaining Friday that she denied the motion in March because Aventis could have and should have made it before the closure of more than four years of discovery.
September 30, 2019
A former Sanofi U.S. Services Inc. employee urged a Pennsylvania federal judge to find that an incentive program by the drugmaker was a kickback scheme, arguing the company's own documents show the program's purpose was to get doctors to prescribe a Sanofi medication for unapproved uses.
May 22, 2018
A Pennsylvania federal judge has ordered Sanofi to hand over hundreds of documents, including any warnings that food and drug regulators may have issued, said to pertain to a suit alleging it marketed off-label uses of a cancer drug.
April 13, 2018
A whistleblower told a Pennsylvania federal court Thursday that Sanofi should be required to hand over in discovery hundreds of documents it claims are protected by attorney-client privilege in a suit alleging it unlawfully marketed off-label uses of a cancer drug, violating the False Claims Act.
January 10, 2017
Sanofi on Monday lost a bid to dodge False Claims Act allegations that it unlawfully marketed off-label uses of a cancer drug when a Pennsylvania federal judge said there was a genuine dispute over whether the marketing was false or misleading.